Reference
Kasaie P, et al. Economic and epidemiologic impact of guidelines for early ART initiation irrespective of CD4 count in Spain. PLOS One : 5 Nov 2018. Available from: URL: https://doi.org/10.1371/journal.pone.0206755
Rights and permissions
About this article
Cite this article
Early ART improves outcomes at acceptable cost in Spain. PharmacoEcon Outcomes News 816, 12 (2018). https://doi.org/10.1007/s40274-018-5432-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-5432-y